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Background: Rhaphidophora korthalsii (Araceae) is a root-climber plant which has been widely used in Chinese
traditional medicine for cancer and skin disease treatment. Previous reports have recorded its immunomodulatory
effects on mice splenocyte and human peripheral blood. This study investigated the potential immunostimulatory
effect of Rhaphidophora korthalsii on human PBMC enriched NK cell.
Methods: PBMC was exposed to various concentrations of R. korthalsii extract and the T and NK cell population in
the control and extract treated PBMC were identified by immunophenotyping. Intracellular perforin and granzyme
B expressions were detected by flow cytometry and extra-cellular Granzyme B, IFN-γ and TNF-α production in the
isolated NK cells were determined by ELISA. The cytotoxicity of effector NK cell towards target K562 cell was
assessed by CytoTox 96 assay.
Results: Rhaphidophora korthalsii methanol extract significantly increased PBMC NK cell population and intracellular
perforin and granzyme B expressions. Moreover, the extract also enhanced the secretion of IFN-γ and TNF-α which
subsequently enhanced the cytotoxicity of NK cell against the NK sensitive target K562 cell line. NK cell enriched
with extract treated PBMC showed better activation than NK cell directly treated with the extract.
Conclusion: Our findings indicated a potential IL-2 free immunotherapy through direct and indirect R. korthalsii
stimulation on NK cell activation.
Keywords: Rhaphidophora korthalsii, NK cell, ImmunomodulationBackground
Immunostimulator is one type of immunomodulator which
can strengthen the body’s immune system [1]. One of the
research directions in complementary medicine is to dis-
cover a safer and effective immunostimulators which can
help in preventing diseases and to be used in clinical prac-
tice for patients with immune disorders. Recent years, the
focus on the study of biological activities such as
immunostimulatory effect from plant extracts based on
ethnopharmacology has been revived all over the world due
to the low or absence of toxicity, complete biodegradability,* Correspondence: noorjahan@biotech.upm.edu.my
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reproduction in any medium, provided the oravailability from renewable resources and low production
cost in comparison to pharmaceutical compounds [2-4].
Rhaphidophora korthalsii, Schott. is a traditional herb
under the family of Araceae. It can be widely found
throughout Asia region such as India, Sri Lanka, Cambodia,
Venezuela, Malaysia, Australia and Indonesia [5]. R.
korthalsii has been traditionally used for cancers and skin
diseases treatment. Earlier studies have found that R.
korthalsii extract possesses selective cytotoxic and antioxi-
dant effects. For example, the extract was found to suppress
P388, Molt 4, KB, SW 620 and T-47D cell lines. The anti-
oxidant activity of the extract had subsequently contributed
to the enrichment of macrophage cell number [6-8]. On
top of that, the extract had also showed to exert immuno-
modulatory effect on mice splenocyte and human per-
ipheral blood mononuclear cell (PBMC) proliferation,d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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and cytotoxicity in vitro and in vivo [8-11].
NK cells are believed to play an important role as effector
cells to lyse cancerous target when compared to other types
of lymphocytes in human immune system. This is because
NK cell forms an early immune defense during innate im-
munity before the emergence of T and B lymphocytes upon
the entrance of pathogen or formation of tumor [12]. To
date, the majority of the studies reported on immunoregu-
lation of R. korthalsii were using a mix population of
lymphocytes. However, little or no information is avail-
able on the modulation of R. korthalsii against targeted
lymphocyte population especially the effects on NK cell.
To address this question, this study was carried out to
present the immunoregulatory effect of R. korthalsii on
human PBMC NK cell activation and cytotoxicity.
Methods
Reagents and chemicals
Fluoroisothiocyanate (FITC)- labeled CD16, CD3, perforin,
granzyme B, and phycoerytherin (PE)-labeled CD56 and
IL-2 neutralizing MQ1-17H12 monoclonal antibodies,
GolgiStop™ solution and Perm/Wash™ solution were pur-
chased from BD, USA; isotype control mouse IgG1 and
FITC goat anti-rabbit Ig were purchased from Abcam,
USA; Enzyme Link Immunosorbent Assay (ELISA) kit for
IFN-γ, TNF-α and Granzyme B cytokines from Bender
MedSystems, Austria; NK cell and T cell isolation kits from
Milteny Biotech, Germany; human recombinant human
Interleukin 2 (rhIL-2), trypan blue solution, DMEM were
brought from Sigma, USA.
Preparation of the methanol extract of R. korthalsii
R. korthalsii methanol extract was prepared using the same
extraction method as stated in our earlier study [9]. R.
korthalsii leaves (voucher no: FRIM 33687) were collected
from Georgetown Herbal Farm, Penang, Malaysia and was
authenticated by Mr. Lim Chung Lu from the Forestry
Division of the Forest Research Institute of Malaysia
(Kepong, Selangor). The leaves were then air-dried and
extracted using 250 mL of methanol (J.T. Baker, USA) for
72 hours. The extract was filtered with Whatman filter
paper no 1 and evaporated to dryness under reduced
pressure using Aspirator A-3S (EYELA, Japan) at < 40°C.
This process was repeated three times (yield 27.3%, w/w)
respectively. The methanol extract was dissolved in DMSO
(Sigma, USA) at a concentration of 10 mg/mL.
Cell line and cell preparation
PBMC was isolated from five different blood donors using
Ficoll-Plaque Plus (Amersham Biosciences, USA) according
to the manufacturer’s protocol. Informed consent was ac-
quired from all donors and this work was carried out in
compliance with the Helsinki Declaration for ethicalapproaches of conducting scientific research. This study was
approved by the ethical committee of University Putra
Malaysia. In brief, one ratio of diluted blood (1:1 ratio in
PBS) sample was layered on 2 ratio of Ficoll-Plaque Plus
(Amersham Biosciences, USA), pelleted (400 g, 40 minutes
at 18-20°C) and the buffy coat was collected, washed twice
with PBS and cultured in DMEM (Sigma, USA) (100 IU/mL
of penicillin, 100 μg/mL of streptomycin [Flowlab, Australia]
and 10% v/v Fetal Bovine Serum [FBS] [PAA, Austria]).
PBMC with viability higher than 90% was subjected to the
following assays.
T cell and NK cell immunophenotyping for human PBMC
The T cell and NK population in the control and extract
treated PBMC were identified using flow cytometry surface
antigen immunophenotyping. In brief, PBMC (5 × 105 cells/
mL) was exposed to various concentrations of R. korthalsii
methanol extract (50 μg/mL, 25 μg/mL or 1 μg/mL) for 24,
48 and 72 hours. Con-A (1 μg/mL) and LPS (1 μg/mL)
treated PBMC and untreated PBMC were used as positive
and negative controls respectively. All samples were then
washed, double stained with 10 μg/10 μL of conjugated
anti-CD3 FITC (isotype control: Mouse IgG2a κ) and
12.5 μg/10 μL of conjugated anti-CD56 PE antibodies
(isotype control: Mouse IgG1 κ) and the population
of CD3+ T cell and CD56+ NK cell were analyzed using
BD FACSCalibur™ flow cytometer with BD CellQuest™
software (BD Biosciences, USA).
NK cell Granzyme B and perforin expressions
PBMC was treated with R. korthalsii extract at 25 μg/mL or
rhIL-2 at 200 U/mL for 72 hours in 6 well plate (BD Biosci-
ences, USA). 2 hours before the end of the incubation
period, the production of perforin and granzyme B were
inhibited by adding and mixing with 2 μL of BD GolgiStop™
into each experimental well. Then, 1 × 106 cells were
harvested, washed with 1 mL of PBS and stained with 12.5
μg/10 μL of conjugated anti-CD 56-PE antibody in a final
volume of 100 μL PBS for 30 minutes at 4°C. After that, the
cells were washed and incubated with 250 μL of Fixation/
Permeabilization solution (BD Biosciences, USA) for 20 mi-
nutes at 4°C. Subsequently, the cells were then washed
twice with BD Perm/Wash™ buffer, incubated with 5 μL of
either 10 μg/10 μL of mouse anti-human Granzyme B-
FITC (Isotype control: Mouse IgG1, κ) (BD Biosciences,
USA) or 10 μg/10 μL of mouse anti-human Perforin-FITC
antibody (Isotype control: Mouse IgG2b, κ) (BD Biosci-
ences, USA), stained with second antibodies and analyzed
using BD FACSCalibur™ flow cytometer with BD
CellQuest™ software (BD Biosciences, USA).
NK cell Isolation
The PBMC was subjected to activation and treatment as
stated below and summarised in Figure 1.
72 hours incubation
Figure 1 Brief description of NK cells treatment. G1 to G4 are the groups of treatment. Direct and indirect activations of R. korthalsii against
NK cells were studied through isolation of NK cells before and after 72-hour incubation with the extract.
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and subjected to NK cell magnetic isolation
Group 2: PBMC was treated with 200 IU/mL of human
rIL-2 treated for 72 hours before subjected to NK cell
isolation
Group 3: Direct NK cells activation whereby freshly
isolated PBMC was subjected to NK cell isolation and
was further cultured in 25 μg/mL of R. korthalsii
methanol extract for 72 hours.
Group 4: Indirect NK cell activation whereby PBMC
was treated with 25 μg/mL of R. korthalsii methanol
extract for 72 hours before subjected to NK cell
magnetic isolation.
NK cell isolation kit by immunomagnetic negative
selection (Milteny Biotech, Germany) was used to isolate
primary NK cells from isolated PBMC. In brief, either
the freshly isolated PBMC (for direct R. korthalsii methanol
extract treatment) or the PBMC cultured 3 days with
different treatment was magnetically labeled with a cocktail
of NK cell Biotin-Antibody Cocktail followed by NK cell
MicroBead Cocktail. The magnetically labeled cells were
then separated using MS column in the magnetic field of
the MACS separator. Purity of NK cells was quantified by
using flow cytometry where the entire isolated NK cell was
labeled with anti-CD16-FITC (isotype control: Mouse IgG1
κ), anti-CD-56-PE (isotype control: Mouse IgG1 κ) and ana-
lyzed by flow cytometer (BD Biosciences, USA). Isolated NK
cell with purity more than 95% were used for further studies.
ELISA for determination of extra-cellular Granzyme B,
IFN-γ and TNF-α
Expressions of Granzyme B, IFN-γ and TNF-α were
performed using Cytokine Enzyme Link ImmunosorbentAssay (ELISA) kit (Bender MedSystems, Austria). In brief,
the extracted human NK cells after 72 hours of different
treatments were cultured for another 24 hours without
treatment. Another group of direct and indirect extract
treated NK cells were treated with 15 μg/mL of MQ1-
17H12 antibody (BD, USA) to neutralize the activity of IL-2
contributed mainly by the surrounding cell especially in the
indirect extract treated NK cell. Similarly, CD3 T cells were
isolated using CD3 T cell isolation kit by immunomagnetic
positive selection based on the same grouping for the NK
cell in Figure 1. The supernatant of these different control
and treatment groups of T cell were subjected to ELISA de-
termination of extra-cellular Granzyme B, IFN-γ and TNF-α
levels and compared their effects with the treatments on the
NK cell. The supernatant from each group was collected,
added into the pre-coated plate of the kit and incubated for
3 hours. After that, these samples were washed and immedi-
ately added with 3,3′,5,5″-tetramethylbenzidine (TMB)
Peroxidase substrate followed by 1 M Phosphoric acid stop
solution. The ELISA plate was read at absorbance OD of
450 and 620 nm wavelengths using a μQuant ELISA
Reader (Bio-Tek Instruments, USA). The results were
expressed in pg/mL. Each experimental and control
sample was assayed in three biological replicates. Data
were expressed as pg/mL.
In vitro cytotoxicity of NK cell on NK cell sensitive K562
cell line
The cytotoxicity of effector NK cell towards target K562 cell
in the ratio of 2:1 and 10:1 for 24 hours was determined
using CytoTox 96 nonradioactive cytotoxicity assay kit
(Promega, USA) according to the manufacturer’s protocol.
The percentage of cytotoxicity was calculated using
the formula below
% Cytotoxicity ¼ OD sampleOD target spontaneousOD effector spontaneous
OD target spontaneousOD effector spontaneous  100
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All tests were carried out with 3 independent experiments
and each of the experiment consisted of 3 technical
replicates. All results are expressed as Mean ± Standard
Error (S.E.M.). Significant levels (p < 0.05) were evaluated
using ANOVA test (one way) followed by post hoc
Duncan test.
Results
R. korthalsii methanol extract increased the PBMC NK cell
population
The changes of CD3+ T cell and CD56+ NK cell
composition in PBMC after treated with R. korthalsii
methanol extract were analyzed using flow cytometry.
Based on the results in Table 1, human PBMC incubated
with 25 μg/mL of extract led to a decreased number of
the T cell population (CD3+CD56-) by 1.13 times but
significantly (P < 0.05) increased the NK cell (CD3-CD56+)
population by 1.5 times. On the other hand, 50 μg/mL
of extract stimulated the NK cell population while
maintaining the T cell population which contributed
to less significant changes of the NK cell (CD3-CD56+)
population as compared to 25 μg/mL of extract. Thus,
25 μg/mL of extract stimulated proliferation of NK cell
rather than T cell in the PBMC.
R. korthalsii methanol extract enhanced NK cell perforin
and granzyme B expressions
Since R. korthalsii methanol extract activated PBMC
showed significantly higher level of NK cell numbers,
NK cell endocytosis production of the apoptosis orTable 1 T cell and NK cell immunophenotyping on human
PBMC after treating with various concentrations of R.
korthalsii methanol extract or positive controls for 72 hours
T cell or NK cell population (%)
CD 3+ CD56- CD3- CD56+
Control 55.8 ± 1.3x 9.6 ± 2.7a
R. korthalsii (50 μg/mL) 52.1 ± 2.7 x 12.1 ± 1.3a,b
R. korthalsii (25 μg/mL) 49.0 ± 1.6y 17.5 ± 3.b
R. korthalsii (1 μg/mL) 54.3 ± 1.9x 8.9 ± 1.2a
rhIL-2 (200 IU/mL) 56.2 ± 2.5x 14.1 ± 1.7b
Con-A (1 μg/ml) 61.0 ± 2.4z 6.7 ± 1.4c
LPS (1 μg/ml) 47.9 ± 1.1y 7.8 ± 1.9a,c
Values (n = 9; 3 independent experiments with three technical replicates each)
represent the means ± S.E.M. x, y and z indicate significant different among
the groups for CD 3+CD56- (T lymphocyte) while a, b and c indicate significant
different among the groups for CD 3-CD56+ (NK cell) (P < 0.05).necrosis inducing proteins (Granzyme B and Perforin) in
PBMC were quantified to explore the contribution of
NK cells in PBMC cytotoxicity. As shown in Figure 2
and Figure 3, the rIL-2 and extract treated PBMC
showed a significantly higher level of perforin or
granzyme B co-expressing CD56+ cells (13.52 ± 1.16%
and 13.82 ± 2.33% for rIL-2 treated PBMC; 15.72 ± 2.72%
and 15.10 ± 2.73% for extract treated PBMC). The
frequencies of perforin+/CD 56- and Granzyme B+/CD
56- populations were only upregulated by the extract
treated PBMC but not significant by rhIL-2 treated
PBMC (Figures 2 and 3). From these results, both rIL-2
and extract were able to stimulate higher percentage of
NK cell population with majority of CD56+ (> 75 %)
co-expressed perforin and granzyme B as compared
to control (~61% for perforin and ~51% for granzyme B)
(This was calculated based on the CD56+ Perforin or
Granzyme B+ population divided by Total CD56+
population from Figures 2 and 3).
R. korthalsii methanol extract enhanced
CD56brightCD16dim NK cell population
At least 95% of the isolated cells was CD56+ as shown in
the upper and lower right columns of Figure 4. Treatments
with rIL-2 and R. korthalsii extract were able to increase
CD56brightCD16dim NK cell population.
R. korthalsii favored NK cell IFN-γ and TNF-α secretion
Together with the induction of intracellular perforin and
granzyme B expressions, R. korthalsii methanol extract
was also able to stimulate extracellular IFN-γ and
TNF-α production either by direct or indirect stimulation
of the NK cells. When NK cells were cultured with 72
hours of extract, the expression of IFN-γ and TNF-α were
increased markedly as compared to the untreated control
group or even with the human rIL-2 treated group
whereas the secretion of granzyme B was not affected
(Table 2). The direct extract activated NK cells showed a
lower level of IFN-γ and TNF-α production as compared
to indirect activated NK cells. This might be contributed
by the uptake of cytokine (e.g. IL-2) produced by the
neighbouring lymphocytes which were also stimulated by
the extract in the same time. Thus, the level of IFN-γ and
TNF-α production were found to be the highest in the
indirect extract treated NK cells followed by the direct
extract treated NK cells and human rIL-2 treated NK cells.
These results were supported by the reduction of IFN-γ
and TNF-α secretions in the indirect extract treated NK
Figure 2 CD 56 and Perforin expression of (A) isotype control (B) untreated, (C) rhIL-2 treated or (D) R. korthalsii methanol extract
treated PBMC. Values (n = 9; 3 independent experiments with 3 technical replicates each) represent the means ± S.E.M. * Significant (P < 0.05).
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cells with the presence of IL-2 neutralizing antibody
MQ1-17H12 (BD, USA).
R. korthalsii enhanced NK cell cytotoxicity
The exposure of human natural killer cell to R. korthalsii
extract directly or indirectly were associated with the
activation of NK cell activity against the targeted cancer
cell. A standard LDH microcytotoxicity assay was subse-
quently performed to quantify the cytotoxicity of the
treated and non-treated NK cells against NK cell sensitive
K562 cell line. Figure 5 showed that LDH was released in
the culture medium following a 24 hours of treated
or non-treated NK cell exposures towards K562 cell
at the ratio of 2:1 and 10:1. Two-hour-exposure of
K562 cells with NK cells treated directly or indirectly
with 25 μg/mL of R. korthalsii methanol extract raised
LDH leakage to 42 ± 1.7% and 58 ± 4.1% respectively. The
cytotoxicity was further increased when the number of
NK cells increased from 2 times to 10 times against the
total cell number of K562. All of the treated NK cells
showed better cytotoxicity against K562 cells as compared
to untreated NK cells with the differential sensitivities of
the treatments in the following order: R. korthalsii indirect
activated NK cells > rhIL-2 indirect treated NK cells > R.
korthalsii direct activated NK cells > untreated NK cells.Discussion
An immunomodulator is a compound or substance that is
capable of either up-regulating or down-regulating a
specific aspect of the host immune system. IL-2 has been
identified as the NK cell immunomodulator in tumor
immunotherapy. However, low concentration of IL-2
was failed to induce adequate amount of immune cell cyto-
toxicity towards tumor regression while high concentration
of IL-2 can produce a severe lymophopenia and toxic side
effect [13,14]. Thus, searching for novel immunomodulator
which can work synergistically with IL-2 to reduce or
replace its working dosage has been proposed from time to
time and this may contribute to the success of adoptive
immunotherapy in cancer treatment. Previously, the
in vitro and in vivo proliferation and cytokine secretion
studies have showed that R. korthalsii methanol extract has
no suppressive effect but on the other hand has stimulation
effect on mice and human lymphocyte function [8-11]. In
this study, R. korthalsii methanol extract had stimulated
NK cell population in a dosage dependent manner (Table 1).
Low concentration of extract (1 μg/mL) did not alter
significant changes (p < 0.05) on both T and NK cell
population. However, 25 μg/mL specifically promoted the
increased of NK cell population which associated with
slight reduction of T cell population. High concentration of
extract possessed similar effect as rIL-2 where the increased
Figure 3 CD 56 and Granzyme B expression of (A) isotype control (B) untreated, (C) rhIL-2 treated or (D) R. korthalsii methanol extract
treated PBMC. Values (n = 9; 3 independent experiments with 3 technical replicates each) represent the means ± S.E.M. * Significant (P < 0.05).
Figure 4 Flow cytometry analysis of CD56 and CD16 expression of NK cells isolated from treated and non-treated PBMC by using
immunomagnetic negative selection NK cell isolation kit (Milteny Biotech, Germany). Gradual increased of NK cells co-expressed the
CD56bright and CD16dim were observed in A to C. A. Untreated NK cells, B. rIL-2 treated NK cells, C. indirect R. korthalsii methanol extract treated
NK cell. Values (n = 9; 3 independent experiments with 3 technical replicates each) represent the means ± S.E.M. * Significant (P < 0.05).
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Table 2 ELISA Granzyme B, TNF-α and IFN-γ detection of untreated, human rIL-2 treated, direct or indirect R. korthalsii
methanol extract stimulated Human NK cells
Granzyme B TNF-α IFN-γ
(pg/mL)
CD56 NK cell
Untreated NK cells 72.3 ± 9.5i 89.1 ± 11.3x 857.5 ± 19.5a
Human rIL-2 treated NK cells 86.2 ± 4.1i 743.3 ± 15.6y 3672.6 ± 28.1b
Direct R. korthalsii extract treated NK cells 79.1 ± 8.5i 478.9 ± 17.8z 2954.2 ± 27.9c
Indirect R. korthalsii extract treated NK cells 88.5 ± 7.3i 814.1 ± 21.3zz 6238.8 ± 38.2d
Direct R. korthalsii extract treated NK cells + MQ1-17H12 antibody 78.4 ± 5.7i 442.9 ± 26.5z 2713.9 ± 33.5c
Indirect R. korthalsii extract treated NK cells + MQ1-17H12 antibody 83.6 ± 6.2i 527.4 ± 31.3z 3112.2 ± 41.7c
CD3 T cell
Untreated CD3 T cells 66.4 ± 4.7i 84.5 ± 9.3 x 691.2 ± 28.5e
Human rIL-2 treated CD3 T cells 69.8 ± 5.2i 876 ± 24.7zz 2976 ± 36.1c
Direct R. korthalsii extract treated CD3 T cells 65.3 ± 7.1i 215.8 ± 41.2zzz 977.2 ± 28.4f
Indirect R. korthalsii extract treated CD3 T cells 68.2 ± 8.3i 164.5 ± 33.9zzz 756.3 ± 23.9 e
Values (n = 9; 3 independent experiments with three technical replicates each) represent the means ± S.E.M. Significant (P < 0.05). i indicate no significant different
among the groups for Granzyme B; x, y, z, zz, zzz indicate significant different among the groups for TNF-α while a, b, c. d. e and f indicate significant different
among the groups for IFN-γ (P < 0.05).
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of high population of T cell. This phenomenon has
suggested that high concentration of R. korthalsii methanol
extract can work similarly as rIL-2 to stimulate both
population of T and NK cell [15] while 25 μg/mL of
extract selectively stimulated NK cell more than T cell.
In this study, our results showed that extract enhanced
the production of perforin and granzyme B on both CD56+
and CD56- populations in PBMC (Figures 2 and 3). Thus,
up-regulation of PBMC cytotoxicity against tumor target
hepatoblastoma HepG2 cell and erythroleukemia K562 cellFigure 5 Cytotoxicity of treated or non-treated NK cells towards K562
evaluated by LDH microcytotoxicity assay. G1 is untreated NK cells; G2
NK cells; G4 is indirect R. korthalsii extract treated NK cells. Each value repres
replicates each. The differences between the control group and treated groupline [9-11] may be contributed by either the NK (CD56+)
or non-NK (cytolytic T which is CD56-) killer cells.
Previously, Wahlberg et al. [16] showed that NK cells
were the sole effector cells actively involved in killing the
tumor cell target as compared to other potential cytotoxic
immune effector cells such as Tumor-specific cytotoxic T
lymphocytes and cytotoxic NK-T cells. K562 cells are
tumor target cells which are sensitive to NK cell cytolytic
activity. Thus, the reduction of the K562 cells’ viability
might be contributed by the NK cell cytolytic activity
which was further upregulated by the R. korthalsii methanolcell at ratio of effector NK cell to target K562 cell at 2:1 and 10:1
is Human rIL-2 treated NK cells; G3 is direct R. korthalsii extract treated
ents the means ± S.E.M. for 3 independent experiments with 3 technical
were determined by one-way ANOVA (*P < 0.05).
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innate immunity which kill the tumor or virus infected
target cells by using three mechanisms [17]. The first
mechanism is by secreting granules which contain
perforin and granzymes that induce necrosis and
apoptosis respectively. Perforin is a killer-cell specific
cytolytic mediator produced by cytotoxic lymphocytes
and stored in cytoplasmic granules. Both perforin and
granzyme are originated from cytolytic serine-proteinases
family and work synergistically to lyse the cell targeted by
cytolytic lymphocytes such as cytolytic T and NK cells.
These proteins were reported previously to be present in
the rIL-2 induced PBMC and were degranulated towards
the target cells during cell mediated cytotoxicity [18]. IL-2
was previously found to be secreted upon extract
activation [11] at a lower concentration as compared
to the rIL-2 which was used as the control in this
study. Thus, it is possible that up-regulation of perforin and
granzyme B production in the NK cells maybe stimulated
via both extract or IL-2 produced by extract stimulated
lymphocytes. The second mechanism is by TNF receptor
family ligand interaction such as Fas ligand (Fas L)/Fas
pathway [19] and the third would be the secretion of
antitumor cytokine such as IFN-γ. Previous study showed
that HepG2 was resistant towards the TNF family Fas L/Fas
induced apoptosis pathway of NK cell but sensitive to NK
cell granule dependent necrotic death [20]. It was
found that 72 hours of extract activation also induced
high production of extra-cellular T helper 1 cytokine,
IFN-γ [11]. The question to this phenomenon was
which population of cells in PBMC was contributed
to the up-regulation of IFN-γ secretion upon extract
stimulation. The immunophenotyping of PBMC postulated
that high expression of IFN-γ may be contributed by NK
cell population rather than T cell. This was because at that
specific concentration, R. korthalsii methanol extract had
up-regulated the NK cell population while reduced the T
cell population in the CD3 and CD56 immunophenotyping
of the extract treated or none treated PBMC (Table 1).
Modulation on IFN-γ production has previously reported
to affect NK cell cytotoxicity [21]. Thus, enhancement of
immune cell cytolytic activity may be contributed by the
synergistic effect of both cytolytic proteins (granzyme B
and perforin) and also antitumor cytokine (IFN-γ).
Although the exact mechanism of R. korthalsii metha-
nol extract in activating immune cell cytotoxicity is
yet to be fully understood, it is expected that the ac-
tivation may be due to the direct binding effect of
the extract to NK cells or indirect effect of IL-2 se-
creted by accessory cells in PBMC. To confirm the
activation of extract on NK cell, CD56 enriched NK
cell population was isolated from PBMC and subjected
to investigation of perforin, granzyme B and cytokine
expressions.Different treatment groups were setup in order to
elucidate the mechanisms of cytotoxicity activity and NK
cell activation by R. korthlasii methanol extract. We have
previously showed that extract-treated PBMC secreted
higher level of IL-2 production as compared to the non-
treated cells. This result gave an insight that the extract
may not only activate NK cells but also other types of
immune cells in the PBMC culture. Moreover, CD4 T cell
and NK cells were found to work synergistically towards
tumor removal [22]. Thus, in this study, the treated and
non-treated PBMC were cultured for 72 hours prior to NK
cell isolation to allow cell-to-cell interactions for better
cytotoxic effect towards tumor cells. On the other
hand, NK cells which express CD56+CD16−/+ were
also isolated from fresh PBMC (Figure 1) before
treated with R. korthalsii methanol extract for a bet-
ter understanding of the immunoregulatory effect
contributed by direct interaction between the extract
and NK cells. NK cells directly isolated from fresh blood for
direct extract activation shared similar 1:1 ratio of CD16+
and CD16- population as in the non-treated PBMC isolated
NK cells (Figure 4). As compared to untreated PBMC, NK
cells isolated from the rIL-2 or extract treated PBMC
showed an increment of CD56brightCD16dim population.
CD56brightCD16dim NK cell population plays an important
role to produce cytokines such as IFN-γ and only possess
weak cytotoxicity against tumor [23]. The increment of this
population (Figure 4) after stimulated by rIL-2 and R.
korthalsii methanol extract had strong correlation with
higher production (Table 2).
Our previous studies have demonstrated that R.
korthalsii methanol extract could enhance immune cells
proliferation, Th1 cytokine expression and cytotoxicity.
In this study, apart from the direct activation of the
R. korthalsii methanol extract on the NK cells isolated
from fresh human blood, the effect of the extract on
NK cells was also monitored through isolation of NK
cells from the pre-activated PBMC. This approach of
activation was chosen because immune cells activation
involves a signaling cascade from innate immunity to
adaptive immunity which includes multiple types of
immune cells. For example, a change in dendritic
cells self-markers can trigger NK cells activation
which further promotes the activation of dendritic
cells and lead to the priming of Th1 responses [24].
From the results obtained, R. korthalsii methanol
extract had demonstrated both direct and indirect im-
munoregulatory effect on human NK cell cytotoxicity
in vitro.
Although CD56brightCD16dim NK cell population
possessed less cytotoxicity against tumor as compared to
CD56dim NK cell, the present of cytokines especially
IL-2 can significantly improved the cytotoxicity of all
subtypes of NK cell [23]. Thus, isolated NK cell
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higher cytotoxicity against K562 cell. Besides, the way
NK cells counter react with tumor involved not only
the NK cells’ cytolytic activity but also those of the
other cytokines. Krishnaraj and Bhooma [25] found
that senescent NK cells showed cytokine secretory
deficiency which contributed to tumor establishment
and viral infection although NK cell cytotoxicity
remained the same. In this study, the enhancement of
IFN-γ and TNF-α production by the extract activated
NK cells was confirmed by ELISA. The results
showed that the level of IFN-γ expression by pure
NK cell population from either extract direct or indirect
activation were quite similar to the level of IFN-γ
expressed by extract activated PBMC in our previous
report [11]. Furthermore, IFN-γ and TNF-α productions
in extract treated isolated CD3 T cell were much lower as
compared to NK cell. This result gave the idea that IFN-γ
produced by extract activated PBMC was contributed
mainly by the extract direct or indirect activated NK cells
and this results was supported by the IL-2 neutralizing
groups where addition of MQ1-17H12 antibody only
affected the secretion of IFN-γ and TNF-α for the indirect
extract treated NK cell. IFN-γ is a multifunctional
cytokine with wide stimulatory effects on anti-tumoral
immune reactions either through direct cytotoxic
effect on tumor cells or indirect stimulation of
immune effector cells such as macrophages and NK
cells to target on the tumor. IFN-γ mediates NK cells’
cytolytic activity through the increase of the ULBP
level of the tumors cells which then binds to the
NKG2D [26]. Binding of RAET1G3 which is the variant of
ULBPs expressed by HepG2 was found to stimulate NK
cells to further enhance IFN-γ secretion [27]. This idea
had raised the possibility that IFN-γ production stimu-
lated by R. korthasii methanol extract might contribute to
the activation of NK cells’ cytotoxicity against HepG2 and
K562 [9-11]. Enhancement of the NK cell cytolytic activity
toward K562 cell by the extract was confirmed in this
study. However, IFN-γ by itself did not demonstrate a
sufficient amount of cytotoxicity to kill the tumor cells.
Aid from other cytokines such as TNF-α could have
overcome this barrier [28]. Thus, IFN-γ, TNF-α, granzyme
B and perforin stimulation may contribute to a higher
level of NK cells’ cytotoxicity towards K562 cells as
compared to the untreated NK cells. All of the above
results showed strong evidence that activation of R.
korthalsii methanol extract contributes to the enhancement
of NK cell cytotoxicity. In this study, no significant amount
of granzyme B was detected in the supernatant of the
culture. This result carried the message that spontaneous
leakage of granzyme B did not take place in all of the
untreated and treated NK cells. Leakage of Granzyme B
into cytosol and extracellular environment was found toinduce NK cell self-apoptosis, which is termed “Granzyme
B leakage-induced cell death” (GLCD) [29]. Thus, GLCD
did not occur in all of the untreated or treated NK cells in
this experiment as no significant leakage of Granzyme B
was detected.
Conclusion
Our study gave strong indication that synergistic effects
of R. korthalsii methanol extract and IL-2 expressed by
the neighouring cells in the PBMC population produced
a greater net activation over NK cells. NK cells isolated
from the PBMC treated with R. korthalsii methanol extract
resulted in a higher expressions of perforin, granzyme B,
IFN-γ, TNF-α, in comparison to those that were treated
with rIL-2 alone or PBMC isolated NK cell directly treated
with the extract. This finding suggested the potential future
use of R. korthalsii methanol extract as an alternative to
mono-immunotherapy by IL-2 in adoptive immunotherapy.
Future studies should focus on the isolation of the active
compounds present in R. korthalsii and the evaluation of
the effects of these compounds on activation and inhibition
markers of NK cell.
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